Loading stock data…
RKDA
$1.12+0.07 (+6.67%)
Market ClosedLast close May 1
Arcadia Biosciences, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Arcadia Biosciences, Inc. in the Consumer Defensive sector is trading at $1.12. The stock is currently near its 52-week low of $0.89, remaining 62.2% below its 200-day moving average. Technical signals show oversold RSI of 29 and bullish MACD crossover, explaining why RKDA maintains its current current market pressure. The Whystock Score of 25/100 signals elevated caution as indicators diverge.
Ecosystem Influences
Oversold momentum (RSI 29) — potential for technical mean-reversion
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$1.12
Potential Upside
5%
Whystock Fair Value$1.18
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as wel...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$2.24M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.72
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-56.50%
Volume
Today's trading volume
50,415
Recent News
Arcadia Biosciences: Q4 Earnings Snapshot
DALLAS (AP) — Arcadia Biosciences Inc. RKDA) on Thursday reported a loss of $1.3 million in its fourth quarter. On a per-share basis, the Dallas-based company said it had a loss of 98 cents.
Arcadia Biosciences: Q3 Earnings Snapshot
DALLAS (AP) — Arcadia Biosciences Inc. RKDA) on Friday reported earnings of $856,000 in its third quarter. The Dallas-based company said it had net income of 62 cents per share.
Arcadia Biosciences: Q2 Earnings Snapshot
DALLAS (AP) — Arcadia Biosciences Inc. RKDA) on Thursday reported a loss of $4.5 million in its second quarter. On a per-share basis, the Dallas-based company said it had a loss of $3.26.
Arcadia Biosciences Inc (RKDA) Q1 2025 Earnings Call Highlights: Strong Zola Sales and ...
Arcadia Biosciences Inc (RKDA) reports significant growth in Zola coconut water sales and strategic financial maneuvers, despite facing margin pressures and delayed product launches.
Arcadia Biosciences: Q1 Earnings Snapshot
DALLAS (AP) — Arcadia Biosciences Inc. RKDA) on Thursday reported earnings of $2.6 million in its first quarter. On a per-share basis, the Dallas-based company said it had profit of $1.90.